相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models
Matthew Trendowski et al.
INVESTIGATIONAL NEW DRUGS (2015)
Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations
Elie Traer et al.
BLOOD (2014)
Primitive CML cell expansion relies on abnormal levels of BMPs provided by the niche and on BMPRIb overexpression
Bastien Laperrousaz et al.
BLOOD (2013)
Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling
Bin Zhang et al.
BLOOD (2013)
Leukemia cells induce changes in human bone marrow stromal cells
Sara Civini et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Active RHOA favors retention of human hematopoietic stem/progenitor cells in their niche
Bithiah Grace Jaganathan et al.
JOURNAL OF BIOMEDICAL SCIENCE (2013)
Inhibition of actin polymerization decreases osteogeneic differentiation of mesenchymal stem cells through p38 MAPK pathway
Himangshu Sonowal et al.
JOURNAL OF BIOMEDICAL SCIENCE (2013)
Imatinib induces H2AX phosphorylation and apoptosis in chronic myelogenous leukemia cells in vitro via caspase-3/Msti pathway
Yan-jun Zhang et al.
ACTA PHARMACOLOGICA SINICA (2012)
Measurement of imatinib uptake by flow cytometry
Celine Bourgne et al.
CYTOMETRY PART A (2012)
Modeling SDF-1-induced mobilization in leukemia cell lines
Abraham Zepeda-Moreno et al.
EXPERIMENTAL HEMATOLOGY (2012)
BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia
Oliver Hantschel et al.
NATURE CHEMICAL BIOLOGY (2012)
Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness
Alexandre Puissant et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2012)
Rho GTPases and their role in organizing the actin cytoskeleton
Soon-Tuck Sit et al.
JOURNAL OF CELL SCIENCE (2011)
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy
L. S. Steelman et al.
LEUKEMIA (2011)
Rho-Kinase/ROCK: A Key Regulator of the Cytoskeleton and Cell Polarity
Mutsuki Amano et al.
CYTOSKELETON (2010)
Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis
Fabrizio Vianello et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Awakening dormant haematopoietic stem cells
Andreas Trumpp et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells
Ellen Weisberg et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance
Nadine N. Bewry et al.
MOLECULAR CANCER THERAPEUTICS (2008)
cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination
Mathieu J. M. Bertrand et al.
MOLECULAR CELL (2008)
A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche
Yoon-Young Jang et al.
BLOOD (2007)
Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells:: impact on in vivo tumor growth
R. Ramasamy et al.
LEUKEMIA (2007)
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Brian J. Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells
S Chu et al.
BLOOD (2004)
Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells
M Chatterjee et al.
BLOOD (2004)
Critical role for Gab2 in transformation by BCR/ABL
M Sattler et al.
CANCER CELL (2002)
The NH2-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl
XW Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
分享论文
